Subscribe to Newsletter

Business & Regulation

 Business & Regulation Standards & Regulation

Remaining (Pharmaco)Vigilant Post-Brexit

| John Barber

How will pharmacovigliance in the UK and Europe be affected by Brexit?
Business & Regulation Business Practice

The Next Stop for Pharma Outsourcing

| Matthew Moorcroft

What do trends in small molecule drugs mean for contract manufacturers?

Business & Regulation Clinical Trials

Clinical Data Star

| Elisa Cascade

Sitting Down With Elisa Cascade, President of Data Solutions at DrugDev
Business & Regulation Packaging

Serial Killer?

| Jean-Marie Aulnette

Data management is a key factor for success with serialization

Business & Regulation Standards & Regulation

Calling for ANDA Action

| Girish Malhotra

Drug costs could be lowered if review and approval processes were much faster
Business & Regulation Business Practice

Business-in-Brief

| William Aryitey

Free cancer drugs, mispackaged contraceptive pills, and antibiotic action… What's new for pharma in business?
Business & Regulation Quality & Compliance

A Positive-Sum Game

| James Strachan

How important is pharmacovigilance in the post-market safety of drugs?
Business & Regulation Business Practice

What Bad Rep?

| James Strachan

Take a look at the Reputation Institute's ranking of the pharma industry
Business & Regulation Small Molecules

Bringing Down the House

| Stephanie Vine

Is it a waste when manufacturers demolish facilities before they're even used?
Business & Regulation Contract Development Services

The Contract Career Path

| Ian Muir

Sitting Down With... Ian Muir, Managing Director, Aesica, UK.
Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

December Issue of The Medicine Maker